The Drugs Laboratory at the Centre for Laboratory Services and Research (CLSR) of the Ghana Food and Drugs Authority (FDA) has been awarded a WHO-Prequalified Quality Control Laboratory (QCL) Status.
By this achievement, the FDA is now the only food and drugs regulatory agency within the ECOWAS subregion to be recognized internationally as a competent institution that can test medicines and medical products under WHO auspices.
The WHO in a statement said "The results of medicines tested by the FDA will therefore henceforth become acceptable to all countries."

The benefits of this new status of the FDA include:
(i) The Laboratory will serve as a Regional Centre of Excellence and train other National Drug Regulatory Agencies in the sub region;
(ii) The FDA can fully participate in international tenders to analyse products that are to be procured by UN agencies, such as UNICEF and the Global Fund; and
(iii)The Certificate of Analysis for locally manufactured medicines in Ghana shall receive international recognition and thereby boost their permeation into the international market.

With the prequalified lab in Ghana, the African Continental Free Trade Area provides additional opportunity to Ghanaian pharmaceutical companies within the African market.
The FDA’s Laboratory has by this feat become a key international player in the testing and verifying of Finished Pharmaceutical Products to ensure that they meet international standards of safety, quality, and efficacy, and will therefore require all the necessary support to maintain this new status.
Additionally, it is to be noted that, once the FDA’s Laboratory has become a prequalified QCL, the FDA may be invited to participate in WHO prequalification monitoring projects that are undertaken periodically to assess the quality of medicines procured by UN agencies.
"With this accomplishment by the FDA’s laboratory as the only WHO-prequalified laboratory in the ECOWAS subregion, the Authority is in readiness and poised to provide effective regulation to support the national vaccine manufacturing agenda, and ensure access to quality, safe and efficacious vaccines and medicines for the nation and the African Continent," the WHO indicated.
Latest Stories
-
BOST, TOR sign MoU to strengthen Ghana’s downstream sector
54 minutes -
Black Sherif lights up Accra with ‘Share a Coke’ with epic concert experience
1 hour -
Today’s Front pages : Thursday , July 24, 2025
1 hour -
Why competition policy and law matters to Ghana’s 24-Hour+ policy
1 hour -
Education Minister inaugurates UENR governing council
2 hours -
Parliament must act now on anti-witchcraft bill – CHRAJ warns of escalating attacks
2 hours -
Government undertaking comprehensive review of Minerals Commission – Lands Minister
2 hours -
Over 700 Ghanaians scammed and trafficked to Cote d’Ivoire, other West African countries – Ablakwa
2 hours -
Finance Minister Ato Forson to deliver 2025 Mid-Year Budget review today
2 hours -
GACL advises airlines to adjust refuelling plans amid looming fuel crisis
2 hours -
Minority proposes Covid-19 levy as viable financing option for Ghana Medical Trust Fund
2 hours -
Interior Minister mourns slain Kusasi Chief, assures justice
2 hours -
PURC facilitates revenue recovery of GH¢50,659 in UWR
2 hours -
Galamsey fight: Government seizes 425 excavators, other machinery
2 hours -
Ghana approves visa waiver agreements with 4 countries
2 hours